Gene therapy restores vision in a canine model of childhood blindness

Nature Genetics
G M AclandJ Bennett

Abstract

The relationship between the neurosensory photoreceptors and the adjacent retinal pigment epithelium (RPE) controls not only normal retinal function, but also the pathogenesis of hereditary retinal degenerations. The molecular bases for both primary photoreceptor and RPE diseases that cause blindness have been identified. Gene therapy has been used successfully to slow degeneration in rodent models of primary photoreceptor diseases, but efficacy of gene therapy directed at photoreceptors and RPE in a large-animal model of human disease has not been reported. Here we study one of the most clinically severe retinal degenerations, Leber congenital amaurosis (LCA). LCA causes near total blindness in infancy and can result from mutations in RPE65 (LCA, type II; MIM 180069 and 204100). A naturally occurring animal model, the RPE65-/- dog, suffers from early and severe visual impairment similar to that seen in human LCA. We used a recombinant adeno-associated virus (AAV) carrying wild-type RPE65 (AAV-RPE65) to test the efficacy of gene therapy in this model. Our results indicate that visual function was restored in this large animal model of childhood blindness.

References

Jun 24, 1997·Proceedings of the National Academy of Sciences of the United States of America·J G FlanneryW W Hauswirth
Nov 5, 1997·Nature Genetics·F MarlhensC P Hamel
Jul 14, 1998·Nature Genetics·K PetrukhinC Wadelius
Aug 18, 1999·Proceedings of the National Academy of Sciences of the United States of America·J BennettS G Jacobson
May 9, 2000·Methods in Enzymology·T M Redmond, C P Hamel
May 9, 2000·Methods in Enzymology·W W HauswirthN Muzyczka
Jun 28, 2000·Proceedings of the National Academy of Sciences of the United States of America·J P Van HooserK Palczewski
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·J Bennett, A M Maguire

❮ Previous
Next ❯

Citations

May 14, 2008·Archives of Ophthalmology·András M KomáromyGustavo D Aguirre
Sep 14, 2011·Archives of Ophthalmology·T Michael NorkBrian J Christian
Dec 24, 2011·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Keiko MiyaderaDavid R Sargan
Jul 19, 2013·Molecular Genetics and Genomics : MGG·Christian SchönStylianos Michalakis
Oct 9, 2008·Pharmaceutical Research·Ian S Blagbrough, Chiara Zara
Oct 18, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Gregory M AclandSamuel G Jacobson
May 10, 2002·The American Journal of Pathology·James T Rosenbaum
Aug 30, 2008·Biochemistry·Grzegorz BeretaKrzysztof Palczewski
Aug 17, 2012·ACS Chemical Neuroscience·Patrick D Hsu, Feng Zhang
Aug 25, 2011·European Journal of Human Genetics : EJHG·Marian M HumphriesPeter Humphries
Mar 2, 2012·European Journal of Human Genetics : EJHG·Hadas Stiebel-KalishMichael Bach
Aug 13, 2010·Gene Therapy·M J AnnearS M Petersen-Jones
Mar 18, 2011·Gene Therapy·C MussolinoE M Surace
Dec 11, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hilda Petrs-SilvaWilliam W Hauswirth
Dec 25, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Knut StiegerFabienne Rolling
Dec 3, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Francesca SimonelliAlberto Auricchio
Jul 16, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Stylianos MichalakisMathias W Seeliger
Oct 28, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Michael LukasonAbraham Scaria
Apr 1, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Elsa LhériteauFabienne Rolling
Jan 19, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Elodie TouchardFrancine Behar-Cohen
Jul 26, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lolita PetitFabienne Rolling
Jan 30, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Shannon E BoyeWilliam W Hauswirth
Dec 2, 2004·Nature Reviews. Genetics·Nathan B Sutter, Elaine A Ostrander
Jun 18, 2005·Cancer Gene Therapy·Chengwen LiRichard Jude Samulski
Jan 23, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jeannette BennicelliJean Bennett
Apr 29, 2008·The New England Journal of Medicine·James W B BainbridgeRobin R Ali
Apr 29, 2008·The New England Journal of Medicine·Albert M MaguireJean Bennett
May 20, 2011·The New England Journal of Medicine·Val C Sheffield, Edwin M Stone
Aug 17, 2012·The New England Journal of Medicine·Elaine A Ostrander
Sep 24, 2008·Proceedings of the National Academy of Sciences of the United States of America·Artur V CideciyanWilliam W Hauswirth
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·William A BeltranGustavo D Aguirre
Aug 15, 2002·The Journal of Biological Chemistry·Vladimir KuksaKrzysztof Palczewski
Jan 16, 2008·The Journal of Biological Chemistry·Marcin GolczakKrzysztof Palczewski
Apr 9, 2002·Human Gene Therapy·Andrew J LoteryBeverly L Davidson
Aug 7, 2002·Human Gene Therapy·Kyoichi TakahashiPeter A Campochiaro
Feb 8, 2003·DNA and Cell Biology·Chooi May LaiP Elizabeth Rakoczy
Sep 9, 2004·Human Gene Therapy·Rene P MolinaTianci Luo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.